Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)95.50
  • Today's Change-1.60 / -1.65%
  • Shares traded300.00
  • 1 Year change+2.14%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 07:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income37714,52612,358
Depreciation/depletion1,8281,8241,578
Non-Cash items12,8615,0102,189
Cash taxes paid, supplemental4,3383,2002,400
Cash interest paid, supplemental1,100937779
Changes in working capital(2205)(2782)(3839)
Total cash from operations13,00619,09514,109
INVESTING
Capital expenditures(3863)(4388)(4448)
Other investing and cash flow items, total(10220)(572)(12107)
Total cash from investing(14083)(4960)(16555)
FINANCING
Financing cash flow items(328)(240)8,210
Total cash dividends paid(7445)(7012)(6610)
Issuance (retirement) of stock, net(1221)384(638)
Issuance (retirement) of debt, net4,184(2251)1,631
Total cash from financing(4810)(9119)2,593
NET CHANGE IN CASH
Foreign exchange effects23(410)(133)
Net change in cash(5864)4,60614
Net cash-begin balance/reserved for future use12,7738,1678,153
Net cash-end balance/reserved for future use6,90912,7738,167
SUPPLEMENTAL INCOME
Depreciation, supplemental1,8281,8241,578
Cash interest paid, supplemental1,100937779
Cash taxes paid, supplemental4,3383,2002,400
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.